BY HELMHOLTZ ZENTRUM MÜNCHEN: Inflammatory processes in the liver lead to elevated cholesterol levels in people with diabetes, thus promoting subsequent vascular diseases. This is the result of a study by scientists of Helmholtz Zentrum München, Technische Universität München (TUM) and the Collaborative Research Center SFB 1118 at Heidelberg University Hospital. The paper, which has now been published in the journal Cell Reports, presents a previously unknown mechanism.
Vascular diseases play a key role among the long-term complications in people with diabetes. Cardiovascular diseases are the most common reason for all hospitalizations, accounting for 75 percent, and these diseases are responsible for fifty percent of all deaths. An important risk factor for atherosclerosis, circulatory disorders and vascular complications is elevated cholesterol. (read more)
BY MICHAEL IRVING: At a glance, One Drop seems like what you’d expect diabetes care to be like in the modern day. It includes a lancet device to draw blood, a glucose meter that sends test results to a smartphone via Bluetooth, and an app that ties everything together. Users can sync information from fitness trackers, monitor their data over time, and easily share it with their doctor. (read more)
BY LEVY PAZ: We need a collective wake-up call. Diabetes is a nasty disease that, over decades, can age virtually every system in the body before you arrive at grim late-stage symptoms like numbness, pain, and infections in the extremities. That’s why it’s imperative that all of us know exactly how well — or how poorly — our bodies handle the sugar and carbs we consume. (read more)